IntegriChain delivers the life science industry’s largest and only data and business process platform for therapy commercialization and access. Manufacturers rely on our analytics, applications, managed services and expert advisors to power their operations and harness the value of their channel, patient and payer data.
View all products
From the first launch to ongoing market access execution, IntegriChain solves some of the most complex and pressing challenges associated with drug commercialization. We are the data and application backbone for market access departments of Life Sciences manufacturers, enabling them to accelerate their commercialization process, digitalize their operations, and get therapies to patients faster.
Solutions overview
To ensure you get the most out of your access and commercialization investment, IntegriChain provides a complete set of professional Advisory and Systems Integration Services designed to further your business and success.
Services overview
IntegriChain provides wide array of resources to help you navigate your journey to market access success.
Resources overview
We help all stakeholders in the life sciences industry drive access. We do this through our relentless focus on unifying all of the critical business functions for therapy commercialization and access – contracts and pricing, gross-to-net, channel, and patient services – unlocking strategic payer, provider, pharmacy and patient access insights for our life sciences customers.
Learn more about our company
Learn more about joining our growing IntegriChain team of data scientists, Market Access experts, analysts, technologies, and advisory professionals – our culture, our purpose, our teams in the US and Pune. Check out our careers or keep in touch for future opportunities.
Keep in touch with IntegrChain through our news and frequent events.
View all news & events
World-class data science drives analytics and applications all accessible from the IntegriChain ICyte Platform combined with outstanding leading Managed Service offerings
Contracts & Pricing
Patient Access
Channel
Gross-to-Net
Learn more about the ICyte Platform
We are an industry leader in Government Pricing Managed Services, providing all relevant calculations required for the Medicaid, Medicare, PHS, and FSS programs. Our GP services are expertly designed with robust data cleansing and standardization, automated data load process, and comprehensive and auditable control reports covering all price calculation detail.
Learn More
Our Rebate Management Managed Services allow customers to scale their payer analytics and contracting functions to meet today’s complex commercial and government access challenges. Our Rebate Management offering is the industry’s leading provider of claims adjudication, handling all of your needs for your claims payments and rebate processing.
IntegriChain’s Chargeback Management Managed Services offers a full suite of chargeback reconciliation and analytics capabilities across GPO/IDN provider and federal contracts such as 340B and FSS. Our offerings marry expert contract management along with unparalleled chargeback processing, uniquely processing the most comprehensive set of validity checks and delivering operational reporting and wholesaler scorecards to better manage your programs.
As more states adopt drug pricing transparency laws to help lower the cost of prescription drugs, pharmaceutical manufacturers, especially those about to launch their first therapy, must understand the changing legal landscape and what it means for their business now and in the future. Watch THE WEBINAR
With a growing population of program participants, the amount of Claim Level Data (CLD) will continue to grow exponentially. Invoice level validations alone cannot bring to light all the potential disputes in the Medicaid data. Without a solid CLD strategy in place, manufacturers are prone to errors and significant revenue leakage. READ eBOOK
Our GTN software for accrual management is an end-to-end revenue solution for your Market Access and Finance departments. Offered as both SaaS and Managed Service, our deployment options are flexible, scalable, auditable, and customizable to your business needs. By automating GTN, you can improve margins, reduce costs, mitigate risk, and drive business decisions based on actionable analytics. MORE ON GTN ACCRUALS
Our industry-leading GTN suite of software solutions and advisory services improves your forecast accuracy, GTN modeling, and financial close efficiency. Offered as both SaaS and Managed Service, our deployment options are flexible, scalable, auditable, and customizable to your business needs. MORE ON GTN forecasts
GTN Analytics rounds out our GTN automation suite of products and complements our GTN Accruals and GTN Forecasts solutions. By offering data access and analytics in a single system of truth and forecast accuracy, we can help you improve management confidence in your data through GTN automation. MORE ON GTN Analytics
Listen OnDemand to Jen Sharpe, Executive Director, Gross-to-Net Solutions of IntegriChain, Kary Callahan, Director, Commercial Finance of Paratek, and Tina Knell, Assistant Director, Revenue of BridgeBio discuss real world GTN transformation using data and analytics. This session was presented at InformaConnect’s BioPharma CFO Digital Week. WATCH THE WEBINAR
In the past year, COVID-19 has expedited efforts for pharmaceutical manufacturers to adopt improved and automated solutions to accurately manage their Gross-to-Net (GTN) forecasting and accrual processes.
READ THE CASE STUDY
With IntegriChain’s Refined Patient Data solution, you can: Get more timely visibility to providers who are struggling with payer restrictions, more accurately measure the impact of patient service programs on patient initiation and adherence and make more informed decisions on patient access investments. IntegriChain’s Refined Patient Data solution utilizes world-class data science and statistical models to monitor, cleanse, and properly map aggregated patient status data, turning a useless mess into actionable data.
More on REFINED PATIENT DATA
IntegriChain’s Specialty Pharmacy Analytics delivers diagnostic patient journey insights by calibrating the datasets associated with a suite of business KPIs and analytics to reflect the uniqueness of your brand’s patient access. Our diagnostic analytics for patient initiation, therapy adherence, field reimbursement, hub services, and patient services go a level deeper to uncover the reasons why your patients are struggling to overcome barriers along the patient journey. More on Specialty Pharmacy Analytics
As the industry pioneer in data aggregation, IntegriChain knows what it takes to pull together troves of data from multiple providers and rapidly make it actionable. Our Patient Data Aggregation solution utilizes our industry leading data science and master data management technology to ensure the accuracy and actionability of patient status data.
More on PATIENT DATA AGGREGATION
Listen to Josh Halpern, Co-Founder & Executive Vice President, Product & Strategy, and Azeem Ahmed, Director, Industry Solutions – Patient Access discuss how the role of data aggregator is undergoing a transformation from tactical departmental solution to an essential backbone of commercialization. WATCH THE WEBINAR
In order to ensure a smooth patient journey and eliminate potential barriers to therapy initiation and adherence, specialty pharmaceutical manufacturers depend on accurate, detailed, and timely patient status updates and dispense data from their specialty pharmacy and hub partners. One of the most mysterious and least understood technologies behind great patient data is data tokenization. This webinar will highlight the role and benefit of tokenization as well as key considerations for achieving best-in-class tokenization.
WATCH THE WEBINAR
Successful market access demands having the right pharmaceutical in the right place at the right time, from distribution center (DC) to points of care (POC). Unfortunately, this is much easier said than done. The myriad of wholesalers, pharmacies, and immense scale of transactions make it difficult for most manufacturers to get an accurate, timely line-of-sight into inventory availability issues. Poor inventory insight not only raises the risk of stock-outs but also creates uncertainty and wide variability to sensitive gross-to-net accrual and incentive compensation processes. IntegriChain’s Channel Data Aggregation solution transforms multiple data streams into the highest quality inventory insights.
Manufacturers have few existing measures of the inventory held in retail stores, distribution centers, and third-party returns processors. IntegriChain Inventory Analytics reports 100% of inventory in the retail channel, even in pharmacy stores and distribution centers that do not report their inventories.
Your visibility to downstream inventory issues is directly related to the quality and quantity of data sets being used to manage your channel. Many manufacturers encounter unpleasant “surprises” due to: Missing and/or blinded product data, discrepancies in sell-in or sell-out data and conflicting inventory and returns data. IntegriChain Refined Channel Data provides an end-to-end view of product distribution starting with life sciences supplier distributor inventory, distributor sales, chain distribution centers (DC) inventory, store inventory, returns, and point of sale (POS) demand.
Distribution Contract Management is a single, auditable application for managing all aspects of trade partner agreements. Configurable trade partner scorecard functionality features payment adjudication, custom pay-for-performance metrics, payment roll forward, and top- and bottom-line functionality adjustments. These functions are automated and facilitate standardized contract negotiations with trade partners. Manufacturers can also monitor trade partner purchase orders in real time and make decisions based on channel inventory and order quantity.More on Distribution Contract Management
A life sciences manufacturer recently launched their first product and faced many challenges along the way. They knew that in order to maximize market access success, they needed a technology partner who was flexible enough to help them scale and adjust for their specific needs and circumstances. READ THE CASE STUDY
COVID-19 has thrust vaccines and new drug innovations to combat viruses front-and-center in the news. During this webinar, IntegriChain will review data and insights to project what the future of COVID therapies may look like.
